The Harvard lab of David Sinclair discusses a chemical cocktail it named SL-100 which, delivered in pill form, restored ...
Juan Andres will come out of retirement to rejoin Moderna as COO on Oct. 5, bringing his intimate knowledge of the company as its Merck-partnered cancer vaccine gathers momentum in the clinic.
Parakeet Health raises a $10M Series A led by Canvas Ventures to expand AI patient outreach beyond dermatology.
The Centers for Medicare and Medicaid Services finalized a demonstration program aimed at lowering the prices of ...
Forget Wegovy and Zepbound. Never mind CagriSema, and even retatrutide. The latest big name in obesity is eloraTZP. Data ...
Merck's tulisokibart showed mid-stage success in hidradenitis suppurativa, with 72% high-dose patients seeing 50%+ abscess ...
Bristol Myers discloses a fatal liver injury in its Phase 3 program for pulmonary fibrosis drug admilparant ahead of a Q4 ...
The failure of a Pfizer antibody-drug conjugate in its important late-stage lung cancer test is exactly what the New York drugmaker didn’t need. The asset, sigvotatug vedotin, was one ...
ARCH and Population Health launch Somnivera with a $10.5M-upfront deal for an ex-China sleep drug from Jiangsu Nhwa.
Former House majority leader Eric Cantor has been chosen as PhRMA’s next CEO, according to two sources familiar ...
A California biotech launched on Tuesday morning to try to bring a niche pain drug, approved in Italy for more than a decade, to the US. Investors are pumping $125 million into the company ...
The cash should give the Stockholm-based biotech a runway “well into 2029,” CEO Patrik Strömberg told Endpoints News in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results